Li et al. reported that melatonin inhibited the biological functions of osteosarcoma cells by repressing the expression of lncRNA JPX through regulating the Wnt/β-catenin signaling pathway, which indicated that melatonin might be applied as a potentially useful and effective natural agent in the treatment of osteosarcoma [88]. This evidence concerns the gene JPX and osteosarcoma.